Latest Royalties News

Fitzroy River has completed the sale of its Bowdens Silver royalty for A$17.5 million, receiving A$10 million in cash and A$7.5 million in Silver Mines shares. The company has not yet disclosed how or when the proceeds will be returned to shareholders.

Albright Metals has established a 54,200-ounce JORC 2012 Mineral Resource at the Vail Road deposit in Canada, including 22,500 ounces in the higher-confidence Indicated category. The estimate gives the company a technical foundation for a Scoping Study, but mine economics and metallurgy remain untested.

Lake Resources has secured the primary provincial environmental permit for its Kachi lithium project in Argentina, clearing the way for detailed engineering and financing work. The approval removes a major development hurdle, but FEED, funding, RIGI approval and a final investment decision remain ahead.

Redcastle Resources has quantified 6,600 ounces of gold already mined and sitting on its ROM pad, but the inventory remains a Mineral Resource rather than an Ore Reserve. The stockpiles are ready to move, although processing arrangements are still being negotiated and mining is currently suspended.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

TG Metals has outlined a preliminary A$26.8 million pre-tax NPV for a low-capital heap leach operation at its Van Uden Gold Project in Western Australia. The economics are striking, but the study remains an early-stage assessment reliant on further drilling, approvals, financing and technical work.

Revolver Resources has taken its Dianne Copper Mine Project from study towards construction readiness, with a larger resource, secured approvals and a forecast $125.7 million pre-tax cash flow. But the restart still depends on project-level funding before a Final Investment Decision can be made.

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Develop Global has issued its first full-year production, operating cost and capital guidance, pairing steady Woodlawn output with the planned start of Pioneer Dome lithium sales. The growth comes with a substantial A$411 million to A$458 million investment program, while Yitirrti remains a construction story until FY28.

Deterra Royalties has paid US$74.15 million for a royalty covering most of Ivanhoe Electric’s Santa Cruz copper project in Arizona. The deal adds a third core asset, but its projected returns still depend on financing, permitting and a targeted 2029 production start.

Accelerate Resources will issue 55 million shares to secure 100% ownership of its 432 square kilometre Woodie Woodie North manganese project, while removing up to $2 million in future milestone payments and other vendor rights. The restructuring is due to complete before 2 October 2026, ahead of planned drilling at the Gingarrigan prospect.

Auravelle Metals has reported encouraging gold results at Sheoak and expanded its Crown project, but its FY2026 annual report flags a material uncertainty over its ability to continue as a going concern. The company lost A$3.98 million, used A$4.07 million in operating cash and held A$632,721 at year end before completing a further A$1.5 million placement.